1207259-18-4

Upstream product

• 1207258-55-6 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole 
• 1207259-90-2 4-(3,5-dimethyl-[1,2,4]triazol-1-yl)-5-methyl-2H-pyrazol-3-ol 
• 1207259-23-1 2-bromo-1-(4-methoxy-2-methyl-phenyl)-propan-1-one 
• 1318780-36-7 benzyl 2-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-oxobutanoate 
• 53773-76-5 1-(4-methoxy-2-methylphenyl)propan-1-one 

Downstream Products

• 1207259-08-2 7-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-2,6-dimethyl-3-(2-methyl-4-trideuteriomethoxy-phenyl)-pyrazolo[5,1-b]oxazole 
• 1318780-35-6 3-(4-(difluoromethoxy)-2-methylphenyl)-7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2,6-dimethylpyrazolo[5,1-b]oxazole 

Relevant academic research and scientific papers

PYRAZOLO[5,1B]OXAZOLE DERIVATIVES AS CRF-1 RECEPTOR ANTAGONISTS

There are described 4-difluoromethoxyphenyl pyrazolo[5.1-b]oxazole derivatives of Formula I: which are useful as corticotropin releasing factor (CRF) receptor antagonists and as pharmaceuticals.

Organic compounds

There are described pyrazolo[5.1-b]oxazole derivatives useful as corticotropin releasing factor (CRF1) receptor antagonists.